Close
ACHEMA MIDDLE EAST 2026

FDA Approves Zynteglo $2.8M Gene Treatment From Bluebird Bio

Gene therapy for blood disorders developed by Bluebird Bio has already left the nest in the US. Zynteglo, sometimes known as betibeglogene autotemcel (beti-cel), was...

ADCs Developed By Starpharma Will Be Evaluated By Merck

As it works to expand its antibody-drug conjugate (ADC) capabilities, Merck has strengthened its links to Starpharma by signing a second partnership that will...

Bayer Hires Lobbyists After Roe To Push Contraception Access

While a large portion of the biopharma industry prepares for a battle over medication prices, Bayer is getting ready for a different lobbying push...

Trodelvy Scores A Breast Cancer Survival Win For Gilead

Gilead staked money on Trodelvy providing a life-extension benefit when it failed to show promise in halting tumour development in HR-positive HER2-negative breast cancer....

Study Identifies And Closes Gaps In Some High-Risk Cancers

A team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director of the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine...

HIV And COVID-19 Vaccines Could Benefit From Nasal Release

A team led by an assistant professor from the University of Minnesota in the US has created a new method to successfully administer vaccines through...

Enhertu of Daiichi Sankyo, AZ Gains HER2-Mutant Lung Cancer

With two significant FDA clearances in as many weeks, Enhertu from AstraZeneca and Daiichi Sankyo is blazing. On August 11th, the medication obtained rapid approval...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...